Polaris Biology logo — Meet the next resolution in medicine

Polaris Biology

Meet the next resolution in medicine

Founded 2016 China Shanghai, China 15 employees Series B Total: $78.25M Biopharma, Biotechnology +1

General Information

Company Name Polaris Biology
Founded Year 2016
Location China Shanghai, China
Employees 15
Industries Biopharma, Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Polaris Biology. To contact Polaris Biology, visit polarisbiology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Polaris Biology

Polaris Biology is a Chinese-based startup founded in 2016 with a focus on biopharma, biotechnology, and healthcare. The company's slogan, "Meet the next resolution in medicine," encapsulates its vision to advance medical solutions. Polaris Biology boasts an advanced single cell platform that enables the simultaneous measurement of biomolecules on each cell, positioning itself on the cutting edge of medical technology. Their most recent milestone was a CNY70.00M Series B investment on 24 June 2020, attracting investments from a diverse group of prominent firms including 5Y Capital, Delian Capital, Emerging Technology Partners, Volcanics Venture, Baidu Venture, 无锡市金融投资有限责任公司, and Ascendin Fund. With its innovative approach and solid financial backing, Polaris Biology presents a compelling investment opportunity in the dynamic landscape of biotech startups.

Taxonomy: Medical Technology, Cell-Level Precision Diagnostic, Tumor Research, Oncology, Immunology, Hematology, Infectious Diseases, Precision Medicine, Single-Cell Analysis, Flow Cytometry, Translational Medicine, Clinical Applications, Biomolecule Measurements, Diagnostic Imaging

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY70.00M 7
5Y Capital, Delian Capital +5
24 Jun 2020
Series A Undisclosed 1
Baidu Venture
05 Sep 2019
Series A $8.25M 2
5Y Capital, Volcanics Venture
21 Jan 2019
Seed Round Undisclosed -
01 Mar 2018

Polaris Biology Alternatives & Competitors

View All Alternatives
Polaris Biology vs

Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse arr...

Acquired
12 employees
Biotechnology, Health Care
Polaris Biology vs
Celldom, Inc.
Celldom, Inc. United States

Find and study cells that make diseases incurable

Seed
8 employees
Biotechnology, Health Care
Polaris Biology vs

Bringing biology into focus—Akoya Biosciences is now Quanterix® Spatial.

Acquired
106 employees
Biotechnology, Health Care

FAQ About Polaris Biology

Meet the next resolution in medicine
Polaris Biology was founded in 2016.
Polaris Biology is headquartered in Shanghai, China.
Polaris Biology operates in Biopharma, Biotechnology and Health Care. Its work centres on Medical Technology, Cell-Level Precision Diagnostic, Tumor Research and Oncology.
Polaris Biology has approximately 15 employees.
Polaris Biology has completed 4 funding rounds, raising a total of $78.25M. The latest funding stage is Series B.
Top alternatives and competitors to Polaris Biology include Tmunity Therapeutics, Celldom, Inc., Akoya Biosciences, Inc., Immunitas Therapeutics, KSL Biomedical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Polaris Biology and Tmunity Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Polaris Biology, https://bouncewatch.com/company/polaris-biology, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes